APOH: A Potential Drug Target Or Biomarker (G350)
APOH: A Potential Drug Target Or Biomarker
APOH, or apo-H, is a protein that is expressed in the liver and has been shown to play a role in the regulation of blood sugar levels. Several studies have suggested that APOH may be a potential drug target or biomarker for various diseases, including diabetes.
One of the key functions of APOH is its role in glucose metabolism. The liver is responsible for filtering glucose in the blood, but it can only do so by sensing the levels of glucose in the blood. APOH helps to regulate the amount of glucose that enters the liver, which is critical for maintaining normal blood sugar levels.
In addition to its role in glucose metabolism, APOH has also been shown to play a key role in the regulation of inflammation. There is evidence to suggest that APOH helps to reduce inflammation in the liver, which is thought to play a key role in the development of many diseases, including diabetes.
Another potential function of APOH is its role in cell signaling. Studies have shown that APOH can interact with a variety of proteins, including the protein kinase A1 (PPK1A). This suggests that APOH may be involved in the regulation of cellular processes that are important for the health and disease.
In addition to its potential drug target and biomarker properties, APOH is also of interest to researchers because of its unique structure and biology. Unlike many proteins, APOH is not a typical protein. It is a large molecule that is made up of multiple domains, including an extracellular domain, a transmembrane domain, and an intracellular domain. This unusual structure is thought to be important for its function, as it allows APOH to interact with other proteins in a variety of ways.
Overall, APOH is a protein that has significant potential as a drug target or biomarker. Its role in glucose metabolism, inflammation, and cell signaling makes it an attractive target for researchers, and its unique structure and biology make it an intriguing molecule. Further studies are needed to fully understand its functions and potential as a drug.
Protein Name: Apolipoprotein H
Functions: Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells
More Common Targets
APOL1 | APOL2 | APOL3 | APOL4 | APOL5 | APOL6 | APOLD1 | Apolipoprotein B mRNA editing complex | APOM | APOO | APOOL | APOOP2 | APOOP5 | APP | APPAT | APPBP2 | APPL1 | APPL2 | APRG1 | APRT | APTR | APTX | AQP1 | AQP10 | AQP11 | AQP12A | AQP12B | AQP2 | AQP3 | AQP4 | AQP4-AS1 | AQP5 | AQP6 | AQP7 | AQP7P1 | AQP7P2 | AQP7P3 | AQP7P5 | AQP8 | AQP9 | AQR | AR | ARAF | ARAP1 | ARAP1-AS2 | ARAP2 | ARAP3 | ARC | ARCN1 | AREG | AREL1 | ARF1 | ARF3 | ARF4 | ARF5 | ARF6 | ARFGAP1 | ARFGAP2 | ARFGAP3 | ARFGEF1 | ARFGEF2 | ARFGEF3 | ARFIP1 | ARFIP2 | ARFRP1 | ARG1 | ARG2 | ARGFX | ARGFXP2 | Arginase | ARGLU1 | ARHGAP1 | ARHGAP10 | ARHGAP11A | ARHGAP11A-DT | ARHGAP11B | ARHGAP12 | ARHGAP15 | ARHGAP17 | ARHGAP18 | ARHGAP19 | ARHGAP19-SLIT1 | ARHGAP20 | ARHGAP21 | ARHGAP22 | ARHGAP22-IT1 | ARHGAP23 | ARHGAP24 | ARHGAP25 | ARHGAP26 | ARHGAP26-AS1 | ARHGAP26-IT1 | ARHGAP27 | ARHGAP27P1 | ARHGAP27P1-BPTFP1-KPNA2P3 | ARHGAP27P2 | ARHGAP28 | ARHGAP29 | ARHGAP30 | ARHGAP31